Adage Capital Partners
CGON icon

Adage Capital Partners’s CG Oncology CGON Stock Holding History

Adage Capital Partners’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1M Buy
+399,858
New +$22.7M 0.04% 390
2025
Q1 		– Sell
-200,000
Closed -$5.74M – 859
2024
Q4 		$5.74M Sell
200,000
-200,000
-50% -$6.84M 0.01% 701
2024
Q3 		$15.1M Buy
400,000
+70,000
+21% +$2.45M 0.03% 525
2024
Q2 		$10.4M Sell
330,000
-125,000
-27% -$4.33M 0.02% 601
2024
Q1 		$20M Buy
+455,000
New +$18.6M 0.04% 452

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners's CGON Position: Q1 2026 in Review

Adage Capital Partners opened a new position in CG Oncology (CGON) in Q1 2026: 399,858 shares worth $27.1M. The stake represents 0.04% of the portfolio and ranks #390 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in CGON as recently as Q4 2024.

Adage Capital Partners first reported a position in CGON in Q1 2024 and has held it in 5 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Adage Capital Partners held 399,858 shares of CG Oncology worth $27.1M as of Q1 2026.
  • CG Oncology was a new Adage Capital Partners position in Q1 2026.
  • CG Oncology made up 0.04% of Adage Capital Partners's portfolio in Q1 2026, its #390 holding.
  • Adage Capital Partners first reported a position in CG Oncology in Q1 2024 and has held it in 5 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.